Reviva Pharmaceuticals Holdings Inc [NASDAQ: RVPH] loss -36.43% or -0.15 points to close at $0.27 with a heavy trading volume of 37523828 shares.
It opened the trading session at $0.265, the shares rose to $0.2667 and dropped to $0.2522, the range by which the price of stock traded the whole day. The daily chart for RVPH points out that the company has recorded -75.76% loss over the past six months.
If we look at the average trading volume of 2.72M shares, RVPH reached to a volume of 37523828 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Reviva Pharmaceuticals Holdings Inc [RVPH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RVPH shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RVPH stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
ROTH MKM have made an estimate for Reviva Pharmaceuticals Holdings Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 20, 2023. While these analysts kept the previous recommendation, The Benchmark Company raised their target price to Speculative Buy. The new note on the price target was released on June 08, 2023, representing the official price target for Reviva Pharmaceuticals Holdings Inc stock. Previously, the target price had yet another raise to $10, while H.C. Wainwright analysts kept a Buy rating on RVPH stock.
Trading performance analysis for RVPH stock
Reviva Pharmaceuticals Holdings Inc [RVPH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -39.72. With this latest performance, RVPH shares dropped by -48.65% in over the last four-week period, additionally sinking by -75.76% over the last 6 months – not to mention a drop of -85.27% in the past year of trading.
Reviva Pharmaceuticals Holdings Inc (RVPH) Capital Structure & Debt Analysis
Reviva Pharmaceuticals Holdings Inc (RVPH) Efficiency & Liquidity Metrics
Reviva Pharmaceuticals Holdings Inc (RVPH) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Reviva Pharmaceuticals Holdings Inc. (RVPH) effectively leverages its workforce, generating an average of -$1936428.57 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.90% and a Quick Ratio of 0.90%, indicating strong ability to cover short-term liabilities.
Reviva Pharmaceuticals Holdings Inc [RVPH]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Reviva Pharmaceuticals Holdings Inc posted -0.25/share EPS, while the average EPS was predicted by analysts to be reported at -0.25/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RVPH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Reviva Pharmaceuticals Holdings Inc go to 21.62%.
An analysis of Institutional ownership at Reviva Pharmaceuticals Holdings Inc [RVPH]
There are presently around $21.07%, or 22.72%% of RVPH stock, in the hands of institutional investors. The top three institutional holders of RVPH stocks are: WOODLINE PARTNERS LP with ownership of 1.59 million shares, which is approximately 5.2129%. MILLENNIUM MANAGEMENT LLC, holding 1.24 million shares of the stock with an approximate value of $$1.59 million in RVPH stocks shares; and MILLENNIUM MANAGEMENT LLC, currently with $$1.31 million in RVPH stock with ownership which is approximately 3.3554%.
